Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Tim Hoctor

Tim Hoctor

Vice President, Life Science Solutions Services

Connect with Tim Hoctor on LinkedIn

About the author: Tim is Vice President, Life Science Solutions Services at Elsevier. He is a technology and Life Science management professional with more than 20 years experience leading products and teams in industry-leading data and analysis products, with a strong emphasis in Life Science and publishing. His career has included roles in communications and user interface development, moving into senior product & strategic marketing, sales, product and professional services management roles. He has a strong understanding of customer perspective and focus, detailed product development and lifecycle management knowledge.

Posts by Tim Hoctor

Big Data vs. Infectious Disease

Posted on October 20th, 2017 in Pharma R&D

With the many highly effective vaccines that have been created over the last several decades, it can be easy (particularly for those in America and other developed countries) to fall into the trap of thinking that we are living in a world where infectious disease is not that big of a threat. (more…)

Wearables in Clinical Trials: Many Benefits, and One Big Challenge

Posted on July 19th, 2017 in Pharma R&D


The rapid development of wearable technology has the power to be a game-changer in many areas, including pharmaceutical R&D. Its most obvious use for pharma is in clinical trials, where recruiting is a frequent challenge, as is getting study participants to adhere to their therapeutic regime. (more…)

How Text-Mining Positively Impacts Early Stage Discovery

Posted on March 29th, 2016 in Pharma R&D

Colleagues, as most of you know, text mining is the process to derive high quality structured information from unstructured text, (more…)

The Privilege of Collaboration

Posted on March 22nd, 2016 in Pharma R&D

Colleagues, collaboration is a critical factor in life science, as we all seek to move the needle in extending, and improving quality of, life. (more…)

  1. 1
  2. 2
  3. 3